CRE-ating Success: How I Use Rapid Diagnostic Tests to Manage Carbapenem-Resistant Enterobacterales Bacteremia

CCO Infectious Disease Podcast

English - December 07, 2023 17:57 - 15 minutes - 14.6 MB
Courses Education Science Life Sciences hiv covid-19 cme hepatitis b hbv id medical education coronavirus hepatitis c hcv Homepage Download Google Podcasts Overcast Castro Pocket Casts RSS feed

Previous Episode: Investigational PPAR-delta Agonist for PBC Treatment and Race-Based Considerations for PBC Diagnosis: Conference Coverage of AASLD

Next Episode: Where We Want to Be: The Search for a Cure for HIV

In this podcast, Julie Ann Justo, PharmD, MS, FIDSA, BCPS, discusses treatment of carbapenem-resistant Enterobacterales (CRE) infections, including:

Burden of CRE infections in the United StatesMechanisms of resistanceChanging epidemiologyUse of rapid diagnostic testsIDSA guidance recommendations, including supporting dataApproach to designing treatment regimens, including weighing patient- and infection-related factors

Faculty:

Julie Ann Justo, PharmD, MS, FIDSA, BCPS
Clinical Pharmacist Lead – Infectious Diseases
Inpatient Pharmacy
Dartmouth Hitchcock Medical Center
Lebanon, New Hampshire

Link to full program:
https://bit.ly/41a8Mj0

Link to accompanying ClinicalThought commentary:
https://bit.ly/4865T57

Link to downloadable infographic:
https://bit.ly/3t7NpT2